CLAUDIO PALMA: Open Payments
NPI 1154348464 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 45 payments from 10 companies in 2025. Trend: 2023 $76 · 2024 $95 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Curonix LLC | 6 | $188 |
| Collegium Pharmaceutical, Inc. | 11 | $181 |
| ABBVIE INC. | 10 | $149 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $133 |
| Abbott Laboratories | 2 | $71 |
| Merz Pharmaceuticals, LLC | 2 | $67 |
| PFIZER INC. | 3 | $51 |
| SCILEX PHARMACEUTICALS INC. | 3 | $49 |
| Convatec Inc. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, XTAMPZA, RELISTOR, UBRELVY, Xeomin, QULIPTA, NURTEC ODT, ZTLido.
Industry payments across GA — which companies pay providers there.
